The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Browsing: Parasitic > Malaria
Researchers have demonstrated that a new whole-parasite vaccine could provide up to 100% protection in clinical trials carried out at the University of Tübingen (Germany).
New research links clusters of virulence-associated pir genes in malaria parasites with their ability to persist in the body, sustaining transmission once symptoms have subsided.
Which countries are most affected by malaria? Take a look at our exclusive infographic to learn more about the key facts and figures in this year’s report.